Research Article
Emergency Tracheal Intubation in Patients with COVID-19: Experience from a UK Centre
Table 2
Tracheal intubation data. Data are expressed as n/N (%) or median and interquartile range (IQR).
| Location of tracheal intubation |
| Remote | 35/53 (66%) | Emergency department | 20 (38%) | General medical ward | 15 (28%) |
| Nonremote | 18/53 (34%) | Intensive care unit | 9 (17%) | Operating theatres | 9 (17%) |
| Primary intubator/laryngoscopist |
| Consultant | 49/53 (92%) | Senior trainee | 4/53 (8%) |
| Number of tracheal intubation attempts |
| One | 45/53 (85%) | Two | 7/53 (13%) | Three | 1/53 (2%) | Failed | 0/53 (0%) |
| Laryngoscopy technique |
| Direct laryngoscopy | 4/53 (8%) | Videolaryngoscopy | 42/53 (79%) | Not specified | 7/53 (13%) | Stylet | 45/53 (85%) | Bougie | 6/53 (11%) | Adjunct not required | 2/53 (4%) | Cricoid pressure | 22/53 (42%) |
| Induction drugs |
| Induction agent | | Propofol | 46/53 (87%) | Ketamine | 4/53 (8%) | Thiopentone | 1/53 (2%) | Not specified | 2/53 (4%) |
| Median dose of commonly used drugs | | Fentanyl 94% (50/53) | 2.5 mcg/kg (IQR 0.66) | Propofol 87% (46/53) | 1.22 mg/kg (IQR 0.7) | Rocuronium 94.3% (50/53) | 1.20 mg/kg (IQR 0.27) |
|
|